You are here

Macrogenics

MacroGenics pauses work on vobra duo ADC pending mature survival data

Fierce Biotech

Wed, 11/6/24 - 11:39 am

antibody drug conjugate

prostate cancer

Five Deaths in Prostate Cancer Trial Send MacroGenics’ Stock Plummeting

BioSpace

Fri, 05/10/24 - 11:16 am

clinical trials

antibody-drug conjugate

vobramitamab duocarmazine

prostate cancer

AbbVie ends stay with the ADAM family, dropping MacroGenics-partnered ADC in light of early data

Fierce Biotech

Fri, 03/8/24 - 11:07 am

Canadian royalty investor buys into first-of-its-kind Type 1 diabetes drug

BioPharma Dive

Fri, 03/10/23 - 09:53 am

DRI Healthcare Trust

type 1 diabetes

Gilead, MacroGenics Unite Against Hematologic Cancers in $1.7B Biobuck Deal

BioSpace

Mon, 10/17/22 - 10:26 am

Gilead Sciences

hematological cancers

drug development

MacroGenics closes solid tumor clinical trial after 7 people die

Fierce Biotech

Mon, 07/11/22 - 10:22 am

clinical trials

MacroGenics flips over an OS dud for cancer drug Margenza in surprising turnaround from earlier data

Endpoints

Tue, 09/7/21 - 10:48 pm

No fast way to eighth place for Incyte

EP Vantage

Fri, 06/25/21 - 10:58 am

monoclonal antibodies

ASCO 2021 movers – PDS wins, but big pharma reigns

EP Vantage

Wed, 06/9/21 - 11:00 am

PDS Biotechnology

Spectrum Pharma

Black Diamond Therapeutics

Alpine Immune Sciences

Harpoon Therapeutics

Macrogenics takes another shot at a novel immune checkpoint

EP Vantage

Fri, 04/23/21 - 11:16 am

antibody-drug conjugate

Macrogenics takes another shot at a novel immune checkpoint

EP Vantage

Thu, 04/22/21 - 10:49 am

prostate cancer

metastatic castration-resistant prostate cancer

MacroGenics wins FDA approval of breast cancer drug

BioPharma Dive

Thu, 12/17/20 - 06:15 pm

Esmo 2020 – More encouraging signs for checkpoint bispecifics

EP Vantage

Tue, 09/22/20 - 10:56 am

Here's Why MacroGenics Jumped 156.6% in the First Half of 2020

Motley Fool

Thu, 07/9/20 - 10:29 pm

HER2+ breast cancer

Macrogenics scoops its ASCO bounce

EP Vantage

Fri, 05/8/20 - 10:20 am

4 Stocks Battling Breast Cancer

Motley Fool

Sat, 10/26/19 - 02:18 pm

Seattle Genetics

MacroGenics' Metastatic Breast Cancer Drug Shows Survival Benefits in Phase III Trial

BioSpace

Wed, 10/23/19 - 02:59 pm

metastatic HER2-positive breast cancer

clinical trials

ASCO 2019 – Macrogenics builds a case for margetuximab

EP Vantage

Wed, 06/5/19 - 09:37 am

HER-2 postive breast cancer

Breast cancer survival data buoys Macrogenics and Puma

Biopharma Dive

Thu, 05/16/19 - 11:28 pm

Puma Biotechnology

May 15 ASCO Quick Takes: After-hours pop for Iovance, MacroGenics; plus Takeda, Amgen, Forty Seven

BioCentury

Wed, 05/15/19 - 11:52 pm

cervical cancer

non-small cell lung cancer

HER2-positive metastatic breast cancer

Pages